证券代码：000881 证券简称：中广核技 公告编号：2025-064 中广核核技术发展股份有限公司 关于召开 2026 年第一次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或 重大遗漏。 一、召开会议的基本情况 1.股东会届次：2026 年第一次临时股东会 2.股东会的召集人：董事会 3.本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票上市 规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等法 律、行政法规、部门规章、规范性文件及《公司章程》的有关规定。 4.会议时间： （1）现场会议时间：2026 年 1 月 16 日 15:00 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2026 年 1 月 16 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互联网投票系统投票的 具体时间为 2026 年 1 月 16 日 9:15 至 15:00 的任意时间。 5.会议的召开方式：现场表决与网络投票相结合。 6.会议的股权登记日：2026 年 1 ...

证券代码：000881 证券简称：中广核技 公告编号：2025-067 中广核核技术发展股份有限公司 第十届董事会第三十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 一、董事会会议召开情况 1.中广核核技术发展股份有限公司（以下简称"公司"）第十届董事会第三十 二次会议（以下简称"本次会议"）通知于 2025 年 12 月 26 日以电子邮件形式发 出。 2.本次会议于 2025 年 12 月 29 日下午 15:00 在深圳市福田区深南大道 2002 号中广核大厦北楼 19 层 881 会议室以视频和通讯表决方式召开。 3.本次会议应参加表决董事 9 名，实际参加表决董事 9 名（其中：委托出席 的董事 0 名，董事长盛国福、董事牟文君、于海峰、慕长坤、独立董事黄晓延、 康晓岳以视频方式参会，董事何飞、吴远明、独立董事王满以通讯方式表决）。 4.本次会议由公司董事长盛国福先生主持。公司部分高管人员列席会议。 5.本次会议的召集、召开符合有关法律、行政法规、部门规章、规范性文件 和《公司章程》的规定。 二、董事会会议审议情况 经出席会议的 ...

南财智讯12月30日电，中广核技公告，公司于2025年12月30日收到杨凌浩先生提交的书面辞职报告，杨 凌浩先生由于工作调动，申请辞去公司总会计师、总法律顾问、首席合规官职务，其原定任期为公司第 十届董事会届满为止。辞职后，杨凌浩先生将不在公司担任任何职务。根据《公司法》《公司章程》的 有关规定，杨凌浩先生的辞职报告自送达公司董事会之日起生效。截至本公告披露日，杨凌浩先生未持 有公司股份。 ...

Core Viewpoint - The exhibition "Building a Strong Country Road - Achievements of China's Manufacturing during the 14th Five-Year Plan" showcases significant advancements in China's manufacturing sector, highlighting key technologies such as the "Hualong One" nuclear power technology and proton therapy systems developed by China General Nuclear Power Group (CGN) [1][2] Group 1: Exhibition Overview - The exhibition is co-hosted by the National Museum of China and the Ministry of Industry and Information Technology, running for an estimated five months and featuring over 300 exhibits across six sections [1] - The "Hualong One" nuclear power model is prominently displayed in the "Green Manufacturing" section, emphasizing its role as a national symbol of China's nuclear power capabilities [1] Group 2: Hualong One Nuclear Technology - The "Hualong One" technology can generate nearly 10 billion kilowatt-hours of electricity annually, sufficient to meet the annual electricity needs of 1 million people [1] - This technology has fostered the development of over 5,400 enterprises in the upstream and downstream supply chain and has achieved 100% domestic production capability for its equipment [1] Group 3: Proton Therapy System - The proton therapy system model demonstrates how nuclear technology can enhance public health, with CGN's equipment being included in the Ministry of Industry and Information Technology's directory for major technological equipment promotion [2] - Proton therapy is particularly effective for targeting tumor tissues while minimizing damage to surrounding healthy tissues, making it suitable for pediatric cancer patients [2] Group 4: R&D and Technological Advancements - During the 14th Five-Year Plan, CGN has committed to high-level technological self-reliance, with R&D investment intensity reaching 3.8% by the end of the plan [2] - CGN has achieved significant innovations, including the successful certification of the "Hualong One" technology in the UK and Europe, and the widespread application of the first nuclear-grade digital control system [2] - The company is also advancing in the renewable energy sector, focusing on a "New Energy+" strategy and making progress in the development of solar thermal collectors [2]

Core Viewpoint - The nuclear pollution prevention sector is experiencing significant growth, driven by recent events in Japan that have raised global concerns about nuclear safety and pollution management [1][3]. Company Performance - Companies in the nuclear pollution prevention sector have seen substantial stock price increases, with notable performers including: - Puni Testing (谱尼测试) up 19.95% to 9.32 - Zaiseng Technology (再升科技) up 9.97% to 11.03 - Yinbang Shares (银邦股份) up 5.41% to 13.05 - Guangzhi Technology (光智科技) up 5.23% to 48.27 - Hujiang Materials (沪江材料) up 5.14% to 19.23 [2]. Industry Context - The recent leakage incident at Japan's "Puxian" nuclear reactor, which involved approximately 20 milliliters of radioactive water, has highlighted serious vulnerabilities in Japan's nuclear facility operations and safety regulations [3][4]. - The timing of this incident coincides with Japan's controversial decision to release over 130,000 tons of treated nuclear wastewater from the Fukushima plant, which has sparked significant public opposition and international criticism [4][5]. Market Trends - The nuclear pollution prevention industry is expanding, particularly in China, where the growth of nuclear power plants and advancements in nuclear technology are driving demand for pollution management solutions [6]. - The market for nuclear pollution prevention is expected to grow due to increased concerns about radiation and the need for effective waste management technologies [6]. Sector Segmentation - The nuclear pollution prevention industry can be divided into several segments, including: - Nuclear accident prevention - Nuclear waste treatment - Radiation protection - Decommissioning of nuclear facilities [7]. Relevant Companies and Technologies - Key companies and their technologies in the nuclear pollution prevention sector include: - China General Nuclear Power (中广核技) and China Electric Environmental Protection (中电环保) for nuclear wastewater treatment technologies - Jiarong Technology (嘉戎技术) for membrane separation technology applicable to nuclear wastewater treatment - Hailun Zhe (海伦哲) for biochemical decontamination equipment - Jianlong Micro-Nano (建龙微纳) for specialized molecular sieves for radioactive element removal [8]. - Other notable companies include: - Sun Moon Shares (日月股份) for nuclear storage tank products - Tongyu Heavy Industry (通裕重工) for intelligent nuclear waste treatment equipment - China General Nuclear (中国广核) for nuclear wastewater processing capabilities [8].

12月19日，中广核技（000881）公告称，公司于2025年12月17日接到持股5%以上股东中国大连国际经 济技术合作集团有限公司（简称"国合集团"）函告，获悉国合集团所持有本公司的部分股份被司法再冻 结及轮候冻结。 截至本公告日，国合集团持有本公司118,914,273股，占公司总股本的12.58%，为公司持股5%以上股东 而非控股股东，亦非公司控股股东的一致行动人，其所持公司股份被司法冻结不会影响公司的正常生产 经营。 截至本公告日，国合集团持有公司股份累计被冻结118,914,273股，占其所持有的公司股份的100.00%， 占公司总股本的12.58%。 | 股东名称 持股教量（股） 特股比例 | | --- | 据了解，因金融借款纠纷，大连高新技术产业园区人民法院于12月15日申请将国合集团所持中广核技 14,273股、118,900,000股司法冻结，到期日为2028年12月14日。 12月19日，中广核技（000881）公告称，公司于2025年12月17日接到持股5%以上股东中国大连国际经 济技术合作集团有限公司（简称"国合集团"）函告，获悉国合集团所持有本公司的部分股份被司法再冻 结及轮候冻结 ...

宁波华翔：华翔启源与大寰机器人签订战略合作协议在灵巧手的研发等领域加强合作 宁波华翔公告，2025年12月22日，宁波华翔电子股份有限公司子公司宁波华翔启源科技有限公司与深圳 市大寰机器人科技有限公司共同签订了《战略合作协议》，为加快建设通用机器人产业，推动通用机器 人供应链示范和产品创新双驱动，本着依法合规、优势互补、友好协商、互利共赢的原则，双方拟在通 用人形机器人灵巧手的研发、制造和销售等领域加强合作。本协议无需提交公司董事会或者股东大会审 议，公司将根据后续合作业务的进展情况依法依规及时履行相应的决策程序及信息披露义务。 登录新浪财经APP 搜索【信披】查看更多考评等级 12月22日，旭升集团实际控制人变更为广州市人民政府；凌云光拟不超过500万美元认购智谱香港 IPO；华翔启源与大寰机器人签订战略合作协议，在灵巧手的研发等领域加强合作…… 以下是盘后公告精选： 旭升集团：实际控制人变更为广州市人民政府股票复牌 旭升集团公告，公司控股股东、实际控制人徐旭东及其一致行动人正在筹划涉及所持有公司股份转让事 宜，该事项可能导致公司控制权变更。2025年12月22日，徐旭东、陈兴方、旭晟控股、旭日实业与广州 ...

Group 1 - Rongchang Biotech plans to repurchase shares worth between 20 million and 40 million yuan, with a maximum price of 95 yuan per share, aiming to buy back approximately 21,050 to 42,110 shares, representing about 0.04% to 0.07% of total share capital [1] - Nanya New Materials intends to raise no more than 900 million yuan through a private placement for AI computing power-based high-frequency high-speed copper-clad laminate R&D and working capital [2] - Xiechuang Data has signed a strategic cooperation agreement with Ping An Financial Leasing, aiming for a cooperation scale of 2 billion yuan over three years [3] Group 2 - Chuangshi Technology's controlling shareholder is under investigation and has been placed under detention, having resigned from all positions in the company [4] - Deep Kangjia A has reported overdue shareholder loans to Yikang Technology and Chuzhou Kangxin, totaling approximately 233 million yuan and 395 million yuan respectively, due to repayment issues [5] - Ningbo Yuanyang announced the resignation of two directors due to work adjustments [6] Group 3 - China Merchants Energy has delivered the world's first methanol dual-fuel VLCC oil tanker, with 15 oil tanker orders in hand [7] - Tianyu Co., Ltd. has received a drug registration certificate for hydrochloride trazodone tablets, which are used for treating depression [8] - Haizheng Pharmaceutical has received FDA approval for clinical trials of HS387 tablets for treating advanced solid tumors [9] Group 4 - Warner Pharmaceuticals has obtained a drug registration certificate for isoproterenol hydrochloride injection, used for treating shock and complete atrioventricular block [10] - Hekang New Energy's subsidiary received a government subsidy of 1.5 million yuan, which accounts for 14.57% of the company's latest audited net profit [11] - Duku Culture is planning a change in company control, with stock suspension expected for no more than two trading days [12] Group 5 - Haisco has received acceptance for an IND application for HSK46575 tablets for prostate cancer treatment [13] - *ST Xinyan is executing a capital reserve transfer to increase share capital, resulting in a stock suspension [14] - Nanjing Public Utilities is transferring a 45% stake in a subsidiary for 23.6443 million yuan [15] Group 6 - Action Education plans to repurchase shares worth between 20 million and 25 million yuan, with a maximum price of 45 yuan per share [16] - Bai'ao Tai has received government subsidies totaling 29 million yuan [18] - Weisi Medical intends to sell assets worth 119 million yuan, expecting a profit impact of approximately 10 million yuan [19] Group 7 - Tongyu Communications plans to increase capital by 10 million yuan to introduce investment from Wuchuang Institute [20] - Dongtu Technology's subsidiary is introducing strategic investor Guofeng Investment Fund with a capital increase of 11 million yuan [21] - China General Nuclear Power Technology's shareholder is facing a judicial auction of 2.91% of the company's shares [22] Group 8 - Nanshan Aluminum plans to repurchase shares worth between 300 million and 600 million yuan, with a maximum price of 7.52 yuan per share [23] - Yipin Hong's controlling shareholder has committed to transferring 9.07% equity in Arthrosi without compensation [24] - Sanli Pharmaceutical has signed a technology transfer contract worth 200 million yuan with Hainan University [25] Group 9 - Xin Nuo Wei plans to jointly invest 450 million yuan with Zhongqi Pharmaceutical to establish a joint venture focusing on innovative metabolic drugs [26] - Li Qun Co. has been approved to issue 1 billion yuan in medium-term notes to optimize debt structure and supplement working capital [27] - Dongfang Ocean's subsidiary has received a medical device registration certificate for a procalcitonin test kit [28] Group 10 - Tibet Mining's chairman has resigned due to work adjustments [29] - Wantai Biological's subsidiary has been shortlisted for a national immunization program vaccine procurement project, with a bid price of 27.5 yuan [30] - Xingfu Blue Sea has appointed Zhang Chen as the new deputy general manager [31] Group 11 - Changyuan Donggu has elected Li Yixuan as the vice chairman of the board [32] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuang Robotics for collaboration in humanoid robot development [33] - Yongda Co. has been pre-selected for a procurement project worth approximately 350 million yuan [34] Group 12 - Fuan Pharmaceutical's subsidiary has received a drug registration certificate for hydrochloride trazodone tablets [35] - Nanjing Food reported a 71.03% year-on-year decrease in net profit for November due to rising raw material costs [36] - Changqing Technology's special polymer monomer project has commenced production [37]

证券代码：000881 证券简称：中广核技 公告编号：2025-056 中广核核技术发展股份有限公司 关于持股 5%以上股东部分股份将被司法拍卖的进展 公 告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 特别风险提示： 截至本公告日，中国大连国际经济技术合作集团有限公司（以下简称"国 合集团"）持有本公司 118,914,273 股，占公司总股本的 12.58%，为公司持股 5%以上股东而非控股股东，亦非公司控股股东的一致行动人，其所持公司部分 股份被司法拍卖不会影响公司的正常生产经营。 2025 年 10 月 28 日，中广核核技术发展股份有限公司（以下简称"公司"） 在 《 中 国 证 券 报 》 《 上 海 证 券 报 》 《 证 券 时 报 》 和 巨 潮 资 讯 网 （http://www.cninfo.com.cn）披露了《关于持股 5%以上股东部分股份将被司法拍 卖的公告》（公告编号 2025-050）。近日，公司接到国合集团通知，根据大连高 新技术产业园区人民法院的《拍卖通知书》，国合集团所持有本公司的 2,750 万 股股份将于 202 ...

中广核技公告，持股5%以上股东国合集团所持有公司的2750万股股份将于2026年1月22日至2026年1月 23日止在京东网拍卖，占其所持股份比例的23.13%，占公司总股本的2.91%。国合集团不是公司的控股 股东，其所持股份被司法拍卖不会影响公司的正常生产经营。 ...